Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Year-over-year debt growth rate
5Y CAGR
+73.5%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
15.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 311.39% |
| Q3 2025 | -1.47% |
| Q2 2025 | -1.45% |
| Q1 2025 | -71.31% |
| Q4 2024 | 271.40% |
| Q3 2024 | -51.43% |
| Q2 2024 | 144.15% |
| Q1 2024 | -10.95% |
| Q4 2023 | -57.70% |
| Q3 2023 | -1.31% |
| Q2 2023 | -17.62% |
| Q1 2023 | 40.24% |
| Q4 2022 | -1.10% |
| Q3 2022 | -24.88% |
| Q2 2022 | -0.65% |
| Q1 2022 | -0.63% |
| Q4 2021 | 10.42% |
| Q3 2021 | -0.82% |
| Q2 2021 | -0.79% |
| Q1 2021 | -0.84% |
| Q4 2020 | 19.79% |
| Q3 2020 | -0.93% |
| Q2 2020 | -0.90% |
| Q1 2020 | -0.87% |
| Q4 2019 | 221.48% |
| Q3 2019 | -3.31% |
| Q2 2019 | -3.15% |
| Q1 2019 | 139.87% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | -100.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | -100.00% |
| Q3 2016 | -22.22% |
| Q2 2016 | -25.00% |
| Q1 2016 | 0.00% |